Biofilm-mediated antibiotic tolerance in Staphylococcus aureus from spinal cord stimulation device-related infections

ABSTRACT Staphylococcus aureus is a predominant cause of infections in individuals with spinal cord stimulation (SCS) devices. Biofilm formation complicates these infections, commonly requiring both surgical and antibiotic treatments. This study explored the biofilm matrix composition and antimicrob...

Full description

Saved in:
Bibliographic Details
Main Authors: Francesca Sivori, Ilaria Cavallo, Mauro Truglio, Lorella Pelagalli, Valerio Mariani, Giorgia Fabrizio, Elva Abril, Iolanda Santino, Piera Assunta Fradiani, Mariacarmela Solmone, Fulvia Pimpinelli, Luigi Toma, Roberto Arcioni, Roberto Alberto De Blasi, Enea Gino Di Domenico
Format: Article
Language:English
Published: American Society for Microbiology 2024-12-01
Series:Microbiology Spectrum
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/spectrum.01683-24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846140383369625600
author Francesca Sivori
Ilaria Cavallo
Mauro Truglio
Lorella Pelagalli
Valerio Mariani
Giorgia Fabrizio
Elva Abril
Iolanda Santino
Piera Assunta Fradiani
Mariacarmela Solmone
Fulvia Pimpinelli
Luigi Toma
Roberto Arcioni
Roberto Alberto De Blasi
Enea Gino Di Domenico
author_facet Francesca Sivori
Ilaria Cavallo
Mauro Truglio
Lorella Pelagalli
Valerio Mariani
Giorgia Fabrizio
Elva Abril
Iolanda Santino
Piera Assunta Fradiani
Mariacarmela Solmone
Fulvia Pimpinelli
Luigi Toma
Roberto Arcioni
Roberto Alberto De Blasi
Enea Gino Di Domenico
author_sort Francesca Sivori
collection DOAJ
description ABSTRACT Staphylococcus aureus is a predominant cause of infections in individuals with spinal cord stimulation (SCS) devices. Biofilm formation complicates these infections, commonly requiring both surgical and antibiotic treatments. This study explored the biofilm matrix composition and antimicrobial susceptibility of planktonic and biofilm-growing S. aureus isolates from individuals with SCS-related infections. Whole-genome sequencing (WGS) examined genotypes, virulome, resistome, and the pan-genome structure. The study also analyzed biofilm matrix composition, early surface adhesion, hemolytic activity, and antibiotic-susceptibility testing. WGS revealed genetic diversity among isolates. One isolate, though oxacillin susceptible, contained the mecA gene. The median number of virulence factor genes per isolate was 58. All isolates harbored the biofilm-related icaA/D genes. When assessing phenotypic characteristics, all strains demonstrated the ability to form biofilms in vitro. The antimicrobial susceptibility profile indicated that oxacillin, rifampin, and teicoplanin showed the highest efficacy against S. aureus biofilm. Conversely, high biofilm tolerance was observed for vancomycin, trimethoprim/sulfamethoxazole, and levofloxacin. These findings suggest that S. aureus isolates are highly virulent and produce robust biofilms. In cases of suspected biofilm infections caused by S. aureus, vancomycin should not be the primary choice due to its low activity against biofilm. Instead, oxacillin, rifampin, and teicoplanin appear to be more effective options to manage SCS infections.IMPORTANCESCS devices are increasingly used to manage chronic pain, but infections associated with these devices, particularly those caused by Staphylococcus aureus, present significant clinical challenges. These infections are often complicated by biofilm formation, which protects bacteria from immune responses and antibiotic treatments, making them difficult to eradicate. Understanding the genetic diversity, virulence, and biofilm characteristics of S. aureus isolates from SCS infections is critical to improving treatment strategies. Our study highlights the need to reconsider commonly used antibiotics like vancomycin, which shows reduced activity against biofilm-growing cells. Identifying more effective alternatives, such as oxacillin, rifampin, and teicoplanin, provides valuable insight for clinicians when managing biofilm-related S. aureus infections in patients with SCS implants. This research contributes to the growing evidence that biofilm formation is crucial in treating device-related infections, emphasizing the importance of tailoring antimicrobial strategies to the biofilm phenotype.
format Article
id doaj-art-de6b5b6e6031439b80197a697d433bae
institution Kabale University
issn 2165-0497
language English
publishDate 2024-12-01
publisher American Society for Microbiology
record_format Article
series Microbiology Spectrum
spelling doaj-art-de6b5b6e6031439b80197a697d433bae2024-12-05T14:01:23ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972024-12-01121210.1128/spectrum.01683-24Biofilm-mediated antibiotic tolerance in Staphylococcus aureus from spinal cord stimulation device-related infectionsFrancesca Sivori0Ilaria Cavallo1Mauro Truglio2Lorella Pelagalli3Valerio Mariani4Giorgia Fabrizio5Elva Abril6Iolanda Santino7Piera Assunta Fradiani8Mariacarmela Solmone9Fulvia Pimpinelli10Luigi Toma11Roberto Arcioni12Roberto Alberto De Blasi13Enea Gino Di Domenico14Microbiology and Virology Unit, San Gallicano Dermatological Institute, IRCCS, Istituti Fisioterapici Ospitalieri (IFO), Rome, ItalyMicrobiology and Virology Unit, San Gallicano Dermatological Institute, IRCCS, Istituti Fisioterapici Ospitalieri (IFO), Rome, ItalyMicrobiology and Virology Unit, San Gallicano Dermatological Institute, IRCCS, Istituti Fisioterapici Ospitalieri (IFO), Rome, ItalySultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCR), Mascate, OmanDipartimento di Scienze Medico-Chirurgiche e Medicina Traslazionale, Sapienza University, Rome, ItalyDepartment of Biology and Biotechnology "C. Darwin", Sapienza University, Rome, ItalyMicrobiology and Virology Unit, San Gallicano Dermatological Institute, IRCCS, Istituti Fisioterapici Ospitalieri (IFO), Rome, ItalyDepartment of Neurosciences, Mental Health and Sensory Organs (NESMOS), Sapienza University, Microbiology Unit, Sant'Andrea Hospital, Rome, ItalyMicrobiology Unit, Sant'Andrea Hospital, Rome, ItalyMicrobiology Unit, Sant'Andrea Hospital, Rome, ItalyMicrobiology and Virology Unit, San Gallicano Dermatological Institute, IRCCS, Istituti Fisioterapici Ospitalieri (IFO), Rome, ItalyDepartment of Research, Advanced Diagnostics, and Technological Innovation, Translational Research Area, Regina Elena National Cancer Institute IRCCS, Istituti Fisioterapici Ospitalieri (IFO), Rome, ItalySultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCR), Mascate, OmanDipartimento di Scienze Medico-Chirurgiche e Medicina Traslazionale, Sapienza University, Rome, ItalyMicrobiology and Virology Unit, San Gallicano Dermatological Institute, IRCCS, Istituti Fisioterapici Ospitalieri (IFO), Rome, ItalyABSTRACT Staphylococcus aureus is a predominant cause of infections in individuals with spinal cord stimulation (SCS) devices. Biofilm formation complicates these infections, commonly requiring both surgical and antibiotic treatments. This study explored the biofilm matrix composition and antimicrobial susceptibility of planktonic and biofilm-growing S. aureus isolates from individuals with SCS-related infections. Whole-genome sequencing (WGS) examined genotypes, virulome, resistome, and the pan-genome structure. The study also analyzed biofilm matrix composition, early surface adhesion, hemolytic activity, and antibiotic-susceptibility testing. WGS revealed genetic diversity among isolates. One isolate, though oxacillin susceptible, contained the mecA gene. The median number of virulence factor genes per isolate was 58. All isolates harbored the biofilm-related icaA/D genes. When assessing phenotypic characteristics, all strains demonstrated the ability to form biofilms in vitro. The antimicrobial susceptibility profile indicated that oxacillin, rifampin, and teicoplanin showed the highest efficacy against S. aureus biofilm. Conversely, high biofilm tolerance was observed for vancomycin, trimethoprim/sulfamethoxazole, and levofloxacin. These findings suggest that S. aureus isolates are highly virulent and produce robust biofilms. In cases of suspected biofilm infections caused by S. aureus, vancomycin should not be the primary choice due to its low activity against biofilm. Instead, oxacillin, rifampin, and teicoplanin appear to be more effective options to manage SCS infections.IMPORTANCESCS devices are increasingly used to manage chronic pain, but infections associated with these devices, particularly those caused by Staphylococcus aureus, present significant clinical challenges. These infections are often complicated by biofilm formation, which protects bacteria from immune responses and antibiotic treatments, making them difficult to eradicate. Understanding the genetic diversity, virulence, and biofilm characteristics of S. aureus isolates from SCS infections is critical to improving treatment strategies. Our study highlights the need to reconsider commonly used antibiotics like vancomycin, which shows reduced activity against biofilm-growing cells. Identifying more effective alternatives, such as oxacillin, rifampin, and teicoplanin, provides valuable insight for clinicians when managing biofilm-related S. aureus infections in patients with SCS implants. This research contributes to the growing evidence that biofilm formation is crucial in treating device-related infections, emphasizing the importance of tailoring antimicrobial strategies to the biofilm phenotype.https://journals.asm.org/doi/10.1128/spectrum.01683-24biofilmspinal cord stimulationStaphylococcus aureusvancomycinoxacillin
spellingShingle Francesca Sivori
Ilaria Cavallo
Mauro Truglio
Lorella Pelagalli
Valerio Mariani
Giorgia Fabrizio
Elva Abril
Iolanda Santino
Piera Assunta Fradiani
Mariacarmela Solmone
Fulvia Pimpinelli
Luigi Toma
Roberto Arcioni
Roberto Alberto De Blasi
Enea Gino Di Domenico
Biofilm-mediated antibiotic tolerance in Staphylococcus aureus from spinal cord stimulation device-related infections
Microbiology Spectrum
biofilm
spinal cord stimulation
Staphylococcus aureus
vancomycin
oxacillin
title Biofilm-mediated antibiotic tolerance in Staphylococcus aureus from spinal cord stimulation device-related infections
title_full Biofilm-mediated antibiotic tolerance in Staphylococcus aureus from spinal cord stimulation device-related infections
title_fullStr Biofilm-mediated antibiotic tolerance in Staphylococcus aureus from spinal cord stimulation device-related infections
title_full_unstemmed Biofilm-mediated antibiotic tolerance in Staphylococcus aureus from spinal cord stimulation device-related infections
title_short Biofilm-mediated antibiotic tolerance in Staphylococcus aureus from spinal cord stimulation device-related infections
title_sort biofilm mediated antibiotic tolerance in staphylococcus aureus from spinal cord stimulation device related infections
topic biofilm
spinal cord stimulation
Staphylococcus aureus
vancomycin
oxacillin
url https://journals.asm.org/doi/10.1128/spectrum.01683-24
work_keys_str_mv AT francescasivori biofilmmediatedantibiotictoleranceinstaphylococcusaureusfromspinalcordstimulationdevicerelatedinfections
AT ilariacavallo biofilmmediatedantibiotictoleranceinstaphylococcusaureusfromspinalcordstimulationdevicerelatedinfections
AT maurotruglio biofilmmediatedantibiotictoleranceinstaphylococcusaureusfromspinalcordstimulationdevicerelatedinfections
AT lorellapelagalli biofilmmediatedantibiotictoleranceinstaphylococcusaureusfromspinalcordstimulationdevicerelatedinfections
AT valeriomariani biofilmmediatedantibiotictoleranceinstaphylococcusaureusfromspinalcordstimulationdevicerelatedinfections
AT giorgiafabrizio biofilmmediatedantibiotictoleranceinstaphylococcusaureusfromspinalcordstimulationdevicerelatedinfections
AT elvaabril biofilmmediatedantibiotictoleranceinstaphylococcusaureusfromspinalcordstimulationdevicerelatedinfections
AT iolandasantino biofilmmediatedantibiotictoleranceinstaphylococcusaureusfromspinalcordstimulationdevicerelatedinfections
AT pieraassuntafradiani biofilmmediatedantibiotictoleranceinstaphylococcusaureusfromspinalcordstimulationdevicerelatedinfections
AT mariacarmelasolmone biofilmmediatedantibiotictoleranceinstaphylococcusaureusfromspinalcordstimulationdevicerelatedinfections
AT fulviapimpinelli biofilmmediatedantibiotictoleranceinstaphylococcusaureusfromspinalcordstimulationdevicerelatedinfections
AT luigitoma biofilmmediatedantibiotictoleranceinstaphylococcusaureusfromspinalcordstimulationdevicerelatedinfections
AT robertoarcioni biofilmmediatedantibiotictoleranceinstaphylococcusaureusfromspinalcordstimulationdevicerelatedinfections
AT robertoalbertodeblasi biofilmmediatedantibiotictoleranceinstaphylococcusaureusfromspinalcordstimulationdevicerelatedinfections
AT eneaginodidomenico biofilmmediatedantibiotictoleranceinstaphylococcusaureusfromspinalcordstimulationdevicerelatedinfections